Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia

Treatment for relapsed acute lymphoblastic leukemia (ALL) in children and young adults continues to evolve. Despite optimization of cytotoxic chemotherapeutic approaches and risk-adapted therapy, about 12% of pediatric patients still relapse, and survival rates in this population remain poor. Salvag...

Descripción completa

Detalles Bibliográficos
Autores principales: Glasser, Chana L., Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377227/
https://www.ncbi.nlm.nih.gov/pubmed/37509525
http://dx.doi.org/10.3390/biomedicines11071886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377227/
https://www.ncbi.nlm.nih.gov/pubmed/37509525
http://dx.doi.org/10.3390/biomedicines11071886

Ejemplares similares